
According to reports from Business Standard, Envair Electrodyne reported a standalone net profit of ₹0.02 crore in the quarter ended December 2025, marking a significant turnaround from the net loss of ₹0.61 crore recorded during the corresponding quarter of the previous year. This represents a complete reversal in the company's financial performance, with the company moving from losses to minimal profitability. As per the latest financial data, the company's total income for Q3 FY2026 was ₹0.10 crore, down 27.26% from the previous quarter's ₹0.13 crore and 10.72% lower than the same quarter last year's ₹0.11 crore. The company's EBIT margin improved to 26.93% in Q3 FY2026, while the net profit margin stood at 18.37%.
As reported by Business Standard, the company reported nil sales for both the quarter ended December 2025 and the corresponding quarter of the previous year. This absence of revenue generation across both periods indicates that the company's profitability improvement was achieved through operational efficiency measures rather than business expansion or new sales generation during the quarter. According to the latest quarterly results, the company's total expenses were ₹0.07 crore in Q3 FY2026, showing an 18.64% increase from the previous quarter's ₹0.06 crore but remaining significantly lower than the ₹0.36 crore recorded in Q3 FY2025.
According to the financial data reported by Business Standard, the company's financial performance showed a dramatic improvement when compared to the same quarter in the previous year. The ₹0.02 crore net profit in Q3 FY2026 represents a substantial improvement from the ₹0.61 crore net loss recorded in Q3 FY2025, demonstrating the company's ability to achieve profitability despite maintaining zero sales revenue during both quarters. The company's EBIT grew by 64.51% to ₹0.03 crore in Q3 FY2026 compared to the previous quarter's ₹0.07 crore, while EBIT margin improved significantly to 26.93% from the previous quarter's 55.20%.
As per the latest market data, Envair Electrodyne shares are currently trading at ₹57.25 on NSE, down from the previous day's close of ₹63.0. The company, incorporated in 1981, operates as a Small Cap entity in the Electric/Electronics sector with a market capitalization of ₹26.56 crore. The stock has shown mixed performance with a 3-year revenue CAGR of 11.29% that outperformed its 3-year CAGR of -45.56%. The company's promoter holding stands at 57.52% as of December 2025, with no pledging of shares. Foreign institutional investors hold 0.0% stake while domestic institutional investors maintain 0.0% holdings in the company.
The company's financial metrics show significant improvement with return on equity (ROE) at -5.62% for the latest period, compared to historical figures of 71.35% in FY2023 and -31.17% in FY2024. The return on capital employed (ROCE) stands at 2.10%, while return on assets (ROA) is -5.23%. The company's price-to-earnings ratio (P/E) is -3013.61, indicating the stock is significantly undervalued. The price-to-book ratio (P/B) is 3.53, reflecting the company's asset base relative to its market value. The company's Earnings Per Share (EPS) for Q3 FY2026 is ₹0.04 with a basic EPS of ₹0.02.